吡啶斯的明

Pyridostigmine

Abstract

Because of the low levels of pyridostigmine in breastmilk, amounts ingested by the infant are small and infant serum levels are very low. Pyridostigmine is not expected to cause any adverse effects in breastfed infants. Most mothers with myasthenia gravis are able to nurse successfully with pyridostigmine treatment, but occasionally breastfeeding must be discontinued to avoid excessive fatigue in the mother.

摘要

由于母乳中吡啶斯的明水平较低，婴儿摄入的量很少，且婴儿血清水平非常低。预计吡啶斯的明不会对母乳喂养的婴儿造成任何不良影响。大多数重症肌无力母亲在接受吡啶斯的明治疗时能够成功哺乳，但偶尔必须停止母乳喂养以避免母亲过度疲劳。